LPL Financial
RGLS

LPL Financial’s Regulus Therapeutics RGLS Stock Holding History

LPL Financial’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$17.5K – 5668
2025
Q1 		$17.5K Buy
+10,000
New +$13.2K ﹤0.01% 5272

Other funds holding RGLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

LPL Financial's RGLS Position: Q2 2025 in Review

LPL Financial sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 37,980 shares — an estimated $66.5K sold.

LPL Financial first reported a position in RGLS in Q1 2014 and held it in 15 quarters. The position peaked at $334K in Q1 2014. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

  • LPL Financial reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • LPL Financial sold 37,980 Regulus Therapeutics shares in Q2 2025, an estimated $66.5K.
  • LPL Financial first reported a position in Regulus Therapeutics in Q1 2014 and held it in 15 quarters.
  • LPL Financial's Regulus Therapeutics position peaked at $334K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on LPL Financial's 13F filing for Q2 2025, filed 12 Aug 2025.